Singapore Life buys Zurich portfolio
January 12 2018 by Nick Ferguson-
New Zealand central bank warns Quest Insurance over non-compliance
- November 12
Quest has acknowledged and remedied the breaches of its obligations and is in the process of implementing further risk management measure, RBNZ said.
-
Hallmark Insurance’s parent St Andrew’s Australia Services get APRA nod as holding company
- November 5
The registration allows the firm to oversee one APRA-authorised life insurer and one general insurer under the regulatory framework.
-
Allianz opens talks with India’s Reliance to launch insurance JVs: report
- October 23
While Jio has been looking to rope in a foreign partner for its insurance foray, as exclusively reported by IAN, the current talks follow the German insurer’s plans to exit its JVs with Bajaj Group.
-
Allianz looks to exit decades-old India JV with Bajaj: report
- October 22
It is eyeing an exit from life and general JVs because its Indian partner is not allowing the German insurer to raise its stakes at a discounted price.
-
BHSI | Managing non-Asian exposure in long-tail lines
While US-exposed business can look attractive to Asian carriers, managing the volatility around the long-term results and the ability to model those losses are crucial, say BHSI’s Marc Breuil and Marcus Portbury.
-
Sedgwick | To Handle CAT Claims Well, Multi-Step Preparation is Key
When it comes to risk, it’s not a matter of “if” it’s a matter of “when” an event will occur.
-
HSBC Asset Management | Is it time to relook at Asian currency bonds?
With diversification and performance high on investors’ agendas, it seems a good time for global portfolios to revive allocations in Asian local currency bonds – including Hong Kong dollar (HKD) bonds.
-
PineBridge Investments | Why Asian insurers are exploring private credit and CLOs
The recent rollout of risk-based capital regimes across Asia calls for a closer alignment between insurers’ assets and liabilities. We explore potential ways to maintain a healthy investment yield and robust returns on regulatory capital.
